Integrative single-cell analysis: dissecting CD8 + memory cell roles in LUAD and COVID-19 via eQTLs and Mendelian Randomization

被引:0
作者
Jintao Wu
Xiaocheng Mao
Xiaohua Liu
Junying Mao
Xianxin Yang
Xiangwu zhou
Lu Tianzhu
Yulong Ji
Zhao Li
Huijuan Xu
机构
[1] Nanchang University Jiangxi Medical College,Departments of Blood Transfusion
[2] Institute of Transfusion,Key Laboratory of Jiangxi Province for Transfusion Medicine
[3] Jiangxi Key Laboratory of Transfusion,Department of Thoracic Surgery
[4] The First Affiliated Hospital of Nanchang University,Department of Radiation Oncology
[5] The First Affiliated Hospital of Nanchang University,NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma
[6] The First People’s Hospital of Wenling,Jiangxi Key Laboratory of Translational Cancer Research
[7] Affiliated Wenling Hospital,Department of Clinical Laboratory
[8] Wenzhou Medical University,undefined
[9] The Fifth Affiliated Hospital of Jinan University,undefined
[10] The Fifth Affiliated Hospital of Shantou University,undefined
[11] Jiangxi Cancer Hospital,undefined
[12] Jiangxi Cancer Hospital of Nanchang University,undefined
[13] Jiangxi Cancer Hospital of Nanchang University),undefined
[14] Jiangxi Cancer Hospital,undefined
[15] Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University,undefined
来源
Hereditas | / 161卷
关键词
Single-cell transcriptomics; Immune function; Lung adenocarcinoma; COVID-19; Mendelian randomization;
D O I
暂无
中图分类号
学科分类号
摘要
Lung adenocarcinoma exhibits high incidence and mortality rates, presenting a significant health concern. Concurrently, the COVID-19 pandemic has emerged as a grave global public health challenge. Existing literature suggests that T cells, pivotal components of cellular immunity, are integral to both antiviral and antitumor responses. Yet, the nuanced alterations and consequent functions of T cells across diverse disease states have not been comprehensively elucidated. We gathered transcriptomic data of peripheral blood mononuclear cells from lung adenocarcinoma patients, COVID-19 patients, and healthy controls. We followed a standardized analytical approach for quality assurance, batch effect adjustments, and preliminary data processing. We discerned distinct T cell subsets and conducted differential gene expression analysis. Potential key genes and pathways were inferred from GO and Pathway enrichment analyses. Additionally, we implemented Mendelian randomization to probe the potential links between pivotal genes and lung adenocarcinoma susceptibility. Our findings underscored a notable reduction in mature CD8 + central memory T cells in both lung adenocarcinoma and COVID-19 cohorts relative to the control group. Notably, the downregulation of specific genes, such as TRGV9, could impede the immunological efficacy of CD8 + T cells. Comprehensive multi-omics assessment highlighted genetic aberrations in genes, including TRGV9, correlating with heightened lung adenocarcinoma risk. Through rigorous single-cell transcriptomic analyses, this investigation meticulously delineated variations in T cell subsets across different pathological states and extrapolated key regulatory genes via an integrated multi-omics approach, establishing a robust groundwork for future functional inquiries. This study furnishes valuable perspectives into the etiology of multifaceted diseases and augments the progression of precision medicine.
引用
收藏
相关论文
共 254 条
[1]  
Sung H(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249
[2]  
Ferlay J(2023)Single-cell spatial landscapes of the lung tumour immune microenvironment Nature 614 548-554
[3]  
Siegel RL(2021)Pan-cancer application of a lung-adenocarcinoma-derived gene-expression-based prognostic predictor Brief Bioinform 22 bbab154-771
[4]  
Laversanne M(2022)A case report of neuromyelitis optica spectrum disorder induced by pembrolizumab treatment for lung adenocarcinoma: a clinical and immunohistochemical study BMC Neurol 22 483-676
[5]  
Soerjomataram I(2020)Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma: a Delphi consensus Clin Transl Oncol 22 759-477
[6]  
Jemal A(2022)Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer Nat Commun 13 816-19
[7]  
Bray F(2020)Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells BMC Cancer 20 474-1558
[8]  
Sorin M(2020)Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study BMJ 369 m1985-132
[9]  
Rezanejad M(2021)Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19 Nat Med 27 668-1533
[10]  
Karimi E(2022)Advances in COVID-19 mRNA vaccine development Signal Transduct Target Ther 7 94-R36